Mammography is the dominant method of breast cancer screening in New Zealand. However, mammograms are much less effective with radio-dense tissue (affecting 40% of the screened population).
The University of Canterbury has developed a painless, zero-radiation screening technology unaffected by radio-dense tissue.
Tiro Medical will develop technologies to enable more accurate diagnoses and treatments across a range of medical areas, improving care whilst reducing expenditure. Tiro’s initial focus will be on the breast screening market, developing the University’s technology for use as a supplementary scan to mammography of radio-dense tissue.